Related Experiment Video

Updated: Jun 18, 2026

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

[Role of the stress protein p8 in tumor progression and development of metastasis]

C Cano1, T Hamidi, M J Sandi

  • 1Inserm U624, Stress Cellulaire, Campus de Luminy, 163 Avenue de Luminy, CP 915, 13288 Marseille cedex 9, France.

Pathologie-Biologie
|November 28, 2009
PubMed

Insights

The p8 protein, a key player in cell stress response, surprisingly aids cancer cell growth, drug resistance, and metastasis. Revisiting its role may reveal new therapeutic targets for incurable cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Despite advances, many cancers remain incurable, necessitating novel therapeutic strategies.
  • The role of cell stress response in cancer progression is complex, with some proteins acting as tumor suppressors.
  • Cancer cells must overcome microenvironment stresses for survival and metastasis, relying on an efficient stress response.

Purpose of the Study:

  • To review the multifaceted roles of the p8 protein in carcinogenesis.
  • To explore how p8 influences cancer cell survival, drug resistance, and metastasis.
  • To identify p8 as a potential therapeutic target for aggressive cancers.

Main Methods:

  • Literature review of studies on p8 protein function in cancer.
  • Analysis of data on p8's impact on cancer cell growth and drug resistance.
  • Examination of p8's role in metastasis formation.

Main Results:

  • The p8 protein, a critical component of the cell stress response, confers advantages to cancer cells.
  • p8 enhances cancer cell proliferation, promotes resistance to therapies, and facilitates metastasis.
  • Evidence suggests p8's function shifts from tumor suppression to tumor promotion during cancer progression.

Conclusions:

  • The p8 protein is a significant factor in tumor progression and metastasis.
  • Understanding p8's pro-cancerous functions is crucial for developing new anti-cancer therapies.
  • Targeting the p8 protein may offer a novel strategy against tenacious and incurable cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...